Adding folate to the contraceptive pill: a new concept for the prevention of neural tube defects

被引:8
作者
Holzgreve, Wolfgang [1 ]
Pietrzik, Klaus [2 ]
Koletzko, Berthold [3 ]
Eckmann-Scholz, Christel [4 ]
机构
[1] Inst Adv Res, Berlin, Germany
[2] Univ Bonn, Inst Ernahrungs & Lebensmittelwissensch, Bonn, Germany
[3] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Munich, Germany
[4] Univ Hosp Schleswig Holstein, Dept Obstet & Gynecol, Kiel, Germany
关键词
Folate application; neural tube defects; oral contraceptives; FOLIC-ACID SUPPLEMENTATION; PERICONCEPTIONAL MULTIVITAMIN SUPPLEMENTATION; CONGENITAL-ABNORMALITIES; DIETARY-FOLATE; WOMEN; PREGNANCY; DISCONTINUATION; MALFORMATIONS; FORTIFICATION; ASSOCIATION;
D O I
10.3109/14767058.2011.648672
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although it is proven for a long time that folic acid supplementation in the periconceptional period can prevent neural tube defects (NTDs) effectively, all measures taken so far including food fortification and awareness campaigns so far had only limited success. Since more than 50% of the pregnant women in Europe get pregnant after they have used oral contraceptives (OCs) before, OCs are an ideal vehicle to increase not only the awareness for periconceptional folate application, but they can also help to bridge the gap between the recognition of a pregnancy and closure of the neural tube which is before day 26. In order to reach a truly protective folate level at the critical time period during pregnancy, now OCs are available which contain metafolin. The availability of this innovative type of OC will significantly reduce the number of NTDs.
引用
收藏
页码:1529 / 1536
页数:8
相关论文
共 56 条
[1]   Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: A sociotechnical analysis [J].
Achterbergh, Roos ;
Lakeman, Phillis ;
Stemerding, Dirk ;
Moors, Ellen H. M. ;
Cornel, Martina C. .
HEALTH POLICY, 2007, 83 (2-3) :277-286
[2]  
[Anonymous], PUBL HLTH COUNC NETH
[3]   Controlled study on folate status following folic acid supplementation and discontinuation in women of child-bearing age [J].
Bakker, D. Joyce ;
de Jong-van den Berg, Lolkje T. W. ;
Fokkema, M. Rebecca .
ANNALS OF CLINICAL BIOCHEMISTRY, 2009, 46 :231-234
[4]   Return to fertility following discontinuation of oral contraceptives [J].
Barnhart, Kurt T. ;
Schreiber, Courtney A. .
FERTILITY AND STERILITY, 2009, 91 (03) :659-663
[5]   A cost-effectiveness analysis of folic acid fortification policy in the United States [J].
Bentley, Tanya G. K. ;
Weinstein, Milton C. ;
Willett, Walter C. ;
Kuntz, Karen M. .
PUBLIC HEALTH NUTRITION, 2009, 12 (04) :455-467
[6]   Prevention of neural-tube defects with folic acid in China [J].
Berry, RJ ;
Li, Z ;
Erickson, JD ;
Li, S ;
Moore, CA ;
Wang, H ;
Mulinare, J ;
Zhao, P ;
Wong, LYC ;
Gindler, J ;
Hong, SX ;
Correa, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) :1485-1490
[7]   DIETARY-FOLATE AS A RISK FACTOR FOR NEURAL-TUBE DEFECTS - EVIDENCE FROM A CASE-CONTROL STUDY IN WESTERN AUSTRALIA [J].
BOWER, C ;
STANLEY, FJ .
MEDICAL JOURNAL OF AUSTRALIA, 1989, 150 (11) :613-&
[8]   Neural Tube Defects in Australia: Trends in Encephaloceles and Other Neural Tube Defects Before and After Promotion of Folic Acid Supplementation and Voluntary Food Fortification [J].
Bower, Carol ;
D'Antoine, Heather ;
Stanley, Fiona J. .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2009, 85 (04) :269-273
[9]   Preventing neural tube defects in Europe:: A missed opportunity [J].
Busby, A ;
Armstrong, B ;
Dolk, H ;
Armstrong, N ;
Haeusler, M ;
Berghold, A ;
Gillerot, Y ;
Baguette, A ;
Gjerga, R ;
Barisic, I ;
Christiansen, M ;
Goujard, J ;
Steinbicker, V ;
Rösch, C ;
McDonnell, R ;
Scarano, G ;
Calzolari, E ;
Neville, A ;
Cocchi, G ;
Bianca, S ;
Gatt, M ;
De Walle, H ;
Braz, P ;
Latos-Bielenska, A ;
Gener, B ;
Portillor, I ;
Addor, MC ;
Abramsky, L ;
Ritvanen, A ;
Robert-Gnansia, E ;
Daltveit, AK ;
Aneren, G ;
Olars, B ;
Edwards, G .
REPRODUCTIVE TOXICOLOGY, 2005, 20 (03) :393-402
[10]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P362